Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.765
Handel nachbörslich:
.75
0.75
+
Genetic Technologies Ltd Adr Aktie (GENE) Neueste Nachrichten
Genetic Technologies faces NASDAQ equity shortfall - Investing.com India
Genetic Technologies joins "CancerIQ" platform - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue By Investing.com - Investing.com UK
Genetic Technologies launches geneType on EasyDNA platform - Investing.com
Ascendis Pharma (ASND) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
Genetic Technologies sets sights on U.S. market growth - Investing.com India
Genetic Technologies names new CFO and Company Secretary - Investing.com India
Genetic Technologies Ltd. ADR (GENE) Stock: A Year of Market Fluctuations - The InvestChronicle
Genetic Technologies CFO Steps Down By Investing.com - Investing.com India
HEICO shares target raised, keeps Buy rating on strong outlook By Investing.com - Investing.com India
Barclays maintains FedEx overweight rating, $350 target By Investing.com - Investing.com
Energizer stock PT raised to $375 at Deutsche Bank, reflecting revenue growth By Investing.com - Investing.com
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewswire Inc.
Genetic Technologies to Host Investor Webinar By Investing.com - Investing.com India
Mastercard shareholders vote on board, executive pay, and proposals By Investing.com - Investing.com
Insmed shares target lifted by Evercore ISI on brensocatib optimism By Investing.com - Investing.com UK
Inozyme Pharma reports voting results, re-elects directors By Investing.com - Investing.com
BM Technologies reports annual meeting results By Investing.com - Investing.com
Gilead's HIV prevention trial shows promise with zero infections By Investing.com - Investing.com
FSN E-commerce stock upgraded by ICICI Securities citing growth focus By Investing.com - Investing.com
Crest Nicholson shares target reduced by Deutsche Bank, margin pressures cited By Investing.com - Investing.com
Biomea Fusion stock downgraded at Barclays; price target slashed to $5 from $30 By Investing.com - Investing.com UK
Genetic Technologies Ltd. ADR (GENE) Stock: A Comprehensive 52-Week Review - The InvestChronicle
The Psychology of Genetic Technologies Ltd. ADR Inc. (GENE) Price Performance: Understanding Market Sentiment - The InvestChronicle
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid ... - Investing.com UK
Li-Cycle holdings director Mark Wellings sells shares worth over $36,000 - Investing.com
Hesai Group CFO Louis T. Hsieh steps down By Investing.com - Investing.com
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. ... - The Globe and Mail
GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com
The 8 Best Penny Stocks On Webull (June 2024) - The Stock Dork
The Best Biotech Stocks to Buy - Morningstar
6 Best Genomics Stocks to Buy in 2024 - The Motley Fool
GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com
TEVA: 3 Smart Pharma Picks Serving Gains - StockNews.com
Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement - Investor's Business Daily
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change - Yahoo Finance
GSK: 3 Pharma Stocks Flashing 'Buy' Signals in December - StockNews.com
Top 5 NASDAQ Genetics Stocks - Investing News Network
GSK: 3 Pharma Stocks on the RiseIt's Time to Buy Now - StockNews.com
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes - Frontiers
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it - Stockhead
Gene Slade’s Journey in Mastering Sales and Transforming Businesses - CEOWORLD magazine
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead
The 20 European Biotech Companies to Watch in 2022 - Labiotech.eu
Syncona to acquire Applied Genetic Technologies Corporation - BioPharma-Reporter.com
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities? - Stockhead
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Start of demonstration experiment of algal breeding technology to solve climate change issues -Aiming to establish the world's first useful algae breeding technology by introducing genetic mutation through neutron irradiation- - NTT
Tech - GSK
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit - Stockhead
Pharmacogenomics Market Dynamics, Size, Forecast, 2022-2030 - P&S Intelligence
Pfizer Deepens Commitment to Genetic-Drug Future With Deals - Bloomberg
Check up: 78 biotech companies rocked the boat this week but only one has real news - Stockhead
Genetic Technologies Ltd.ADR Shares Fall 0.8% Below Previous 52-Week LowMarket Mover - Nasdaq
5 Penny Stocks Robinhood Traders are Buying in 2021 - Insider Monkey
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal - Yahoo Finance
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPOiShares ... - Benzinga
74 Biggest Movers From Yesterday - Benzinga
60 Biggest Movers From YesterdayArbutus Biopharma (NASDAQ:ABUS), ARCA biopharma (NASDAQ:ABIO) - Benzinga
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPO - Benzinga
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The SpotlightiShares - Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga
3.48%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):